Company registration number NI028666 (Northern Ireland)
XEROX IBS NI LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
XEROX IBS NI LIMITED
COMPANY INFORMATION
Directors
Ms C A Shephard
(Appointed 1 February 2022)
Ms E Maher
Mr R Clarke
(Appointed 8 March 2022)
Mr D S Cassidy
(Appointed 1 February 2022)
Mr S Farrell
(Appointed 14 October 2022)
Secretary
Ms A Albertoni
Company number
NI028666
Registered office
Forsyth House
Cromac Square
Belfast
BT2 8LA
Auditor
GMcG BELFAST
Alfred House
19 Alfred Street
Belfast
BT2 8EQ
Business address
Plaza 211
Blanchardstown Corporate Park 2
Blanchardstown
Dublin 15
D15 AP2D
Solicitors
Millar McCall Wylie
Eastleigh House
396 Upper Newtownards Road
Belfast
BT4 3EY
XEROX IBS NI LIMITED
CONTENTS
Page
Directors' report
1 - 4
Independent auditor's report
5 - 10
Statement of profit and loss and other comprehensive income
11
Statement of financial position
12
Statement of changes in equity
13
Notes to the financial statements
14 - 31
XEROX IBS NI LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2022
- 1 -
The directors present their annual report and the audited financial statements of Xerox IBS NI Limited ("the company") for the financial year ended 31 December 2022.
Principal activities
The company provides maintenance and document management to customers.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Mr B Baran
(Resigned 1 February 2022)
Mr Anthony McPhillips
(Resigned 1 February 2022)
Ms A C Beckman
(Resigned 31 August 2022)
Ms C A Shephard
(Appointed 1 February 2022)
Ms E Maher
Mr R Clarke
(Appointed 8 March 2022)
Mr D S Cassidy
(Appointed 1 February 2022)
Mr S Farrell
(Appointed 14 October 2022)
In accordance with the Articles of Association, the directors are not required to retire by rotation. Unless indicated otherwise, they served for the entire year.
Results and dividends
The results for the year are set out on page 11.
The results for the year and the financial position at the year-end were considered satisfactory by the directors.
The following key indicators are relevant in reviewing the development, performance, and position of the business.
Revenue
Revenue decreased by £345,657 (11%) to £2,810,217 in 2022. The 2022 revenue was significantly impacted by macro supply chain challenges and the availability of equipment for sale.
Exceptional administrative expense
The significant increase in exceptional administrative expenses is related to redundancy and other associated costs arising from restructuring actions as well as other transformation efforts in order to reduce our cost structure, realign it to the changing nature of our business and achieve operating efficiencies. The expected savings associated with these initiatives may be offset to some extent by business disruption during the implementation phase as well as investments in new processes and systems until such time as the initiatives are fully implemented and stabilized.
Loss
The loss for the financial year was £906,982 for 2022 (up from £527,922 in 2021).
No ordinary dividends were paid. The directors do not recommend payment of a final dividend.
XEROX IBS NI LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 2 -
Financial risk management
The company’s operations expose it to a variety of financial risks that include the effects of price risk, credit risk, liquidity risk, interest rate cash flow risk and foreign currency risk. The company has in place risk management processes that seek to limit the adverse effects on its financial performance by monitoring levels of debt, liquidity and exchange rate risk and the related financial costs. Given the size of the company, the directors have not delegated the responsibility of monitoring financial risk management to a sub-committee of the board.
The policies set by the board of directors are implemented by the company’s finance department. The department has a policy and procedures manual that sets out specific guidelines to manage price risk, credit risk, liquidity risk and interest rate cash flow risk and circumstances where it would be appropriate to use financial instruments to manage these.
(i) Price risk
The company has no exposure to equity securities price risk, as it holds no listed or other traded equity investments. The majority of the goods and services sold by the company are provided from its own resources or are bought in from related parties. Processes exist to provide adequate forewarning of any changes in transfer pricing levels. Transfer pricing levels can be subject to periodic review by national tax authorities.
(ii) Credit risk
The company has implemented policies that require full use of appropriate documentation, structures and credit checks on potential customers before sales are made. Credit risk is managed through the continuous monitoring of exposures to and payment behaviour of counterparties via a network of risk personnel and credit committees under Pan-European direction. Company policy with regard to financial derivatives instruments is to deal only with counterparties having as a minimum investment grade or better credit ratings.
(iii) Liquidity risk
Liquidity Risk is managed by the Xerox Treasury department which ensures that the company has the appropriate funding structure and access to liquidity such that it can meet its operating cash requirements and obligations as they fall due.
(iv) Interest rate cash flow risk
The company has no significant interest bearing assets or interest bearing liabilities with third parties; therefore little risk arises from changes in interest rates to the company in its own right. Xerox Holdings Corporation manages all significant relationships with the external debt market. The directors will revisit the appropriateness of this policy should the company’s operations change in size or nature.
(v) Foreign currency risk
Responsibility for monitoring and managing financial risk lies with Xerox Holdings Corporation’s Treasury Operations department. Typically, Treasury Operations use forward exchange contracts to manage currency risk for payments to related parties in Japanese Yen, US Dollars and Euros in respect of goods and services purchased and technology related royalties.
XEROX IBS NI LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 3 -
Legal and regulatory matters
Concern over climate change, including global warming, has led to legislative and regulatory initiatives directed at limiting greenhouse gas emissions. For example, proposals that would impose mandatory requirements on greenhouse gas emissions continue to be considered by policy makers in the countries, states and territories in which we operate. Laws and/or regulatory actions to address concerns about climate change and greenhouse gas emissions could impact our business, including the availability of our products or the cost to obtain or sell those products. Xerox also recognizes transitional risks associated with changes in voluntary standards and customer preferences in connection with concerns about climate change. If Xerox is unable to offer products that are as energy efficient as our competitors, there is a risk of reduced demand for our products and reduced market share. Inability, or a perception of inability, to achieve progress toward our environmental goals could adversely impact our business or damage our reputation.
Xerox continues its efforts toward monitoring and evaluating the applicability of these and numerous other regulatory initiatives in an effort to develop compliance strategies.
Environment
In the field of environmental protection, the company is not in breach of any rules or regulations. The group strives to operate in such a way as to minimize the environmental impact of its operations. The group operates under the following environmental protection principles:
Reducing energy consumption.
Preserving biodiversity and the world’s forests.
Maintaining clean air and water.
Reducing and managing waste.
Ensuring the health and safety of employees.
Together with our suppliers, customers and shareholders, the company seeks to maintain the highest standards of environmental protection. The company runs initiatives to reduce hardcopy printing and recycles used equipment and parts.
Going Concern
These financial statements have been prepared on a going concern basis. In preparing these financial statements, the directors have assessed that the company will continue in operational existence for the foreseeable future. Further details are set out in note 1.2 to the financial statements.
The company has the continued support of its ultimate parent, Xerox Holding Corporation, which historically has been, and continues to be forthcoming to provide such financial support as the company may require to continue trading as a going concern. Consequently, the directors consider that the company has sufficient resources to meet its financial obligations as they fall due for at least the next twelve months from the date of approval of these financial statements. On that basis, the directors consider it appropriate to prepare the financial statements on a going concern basis.
Future developments
The company does not propose any significant changes in its principal activities.
Political donations
The company did not make any political donations during the year.
Events since the end of the financial year
There were no subsequent events that need disclosure or recognition in the financial statements.
Auditors
The independant auditors GMcG BELFAST, are deemed to be reappointed under section 487(2) of the Companies Act 2006.
XEROX IBS NI LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 4 -
Statement of Directors' Responsibilities
The directors are responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have decided to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards, comprising Financial Reporting Standard 101 – Reduced Disclosure Framework (FRS 101), and applicable law). Under company law, the directors shall not approve the financial statements unless they are satisfied that they give a true and fair view of the company's assets, liabilities and financial position as at the end of the financial year and the profit or loss of the company for the financial year.
In preparing the financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements andestimates that are reasonable and prudent;
state whether Accounting Standards, comprising FRS 101, have been followed, subject to any material departures disclosed and explained in the financial statements; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.
The directors are also responsible for keeping adequate accounting records that are sufficient to:
correctly record company;
disclose with reasonable accuracy at any time the financial position of the company
enable the directors to ensure that the financial statements comply with the Companies Act 2006
The directors are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Disclosure of information to auditors
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditors are unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
On behalf of the board
Ms C A Shephard
Director
28 March 2024
XEROX IBS NI LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF XEROX IBS NI LIMITED
- 5 -
Opinion
We have audited the financial statements of Xerox IBS NI Limited (the 'company') for the year ended 31 December 2022 which comprise the statement of comprehensive income, the statement of financial position, the statement of changes in equity and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 101 Reduced Disclosure Framework.
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 December 2022 and of its loss for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
XEROX IBS NI LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBER OF XEROX IBS NI LIMITED
- 6 -
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the directors' report has been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit; or
the directors were not entitled to take advantage of the small companies exemption from the requirement to prepare a strategic report.
XEROX IBS NI LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBER OF XEROX IBS NI LIMITED
- 7 -
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
XEROX IBS NI LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBER OF XEROX IBS NI LIMITED
- 8 -
Extent to which the audit was considered capable of detecting irregularities, including fraud
We identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and then design and perform audit procedures responsive to those risks, including obtaining audit evidence that is sufficient and appropriate to provide a basis for our opinion.
In identifying and assessing potential risks of material misstatement in respect of irregularities, including fraud and non-compliances with laws and regulations, we considered the following:
The nature of the industry and sector, control environment and business performance, including the company’s remuneration policies for directors, bonus levels and performance targets, if any;
Results of our enquiries of management about their own identification and assessment of the risks of irregularities;
Any matters we identified having obtained and reviewed the company’s documentation of their policies and procedures relating to:
Identifying, evaluating and complying with laws and regulations and whether they were aware of any instance of non-compliance;
Detecting and responding to the risks of fraud and whether they have knowledge of any actual, suspected or alleged fraud; and
The internal controls established to mitigate risks of fraud or non-compliance with laws and regulations;
The matters discussed among the audit engagement team regarding how and where fraud might occur in the financial statements and potential indicators of fraud.
As a result of these procedures, we considered the opportunities and incentives that may exist within the company for fraud and identified the greatest potential for fraud in revenue recognition. In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override.
We also obtained an understanding of the legal and regulatory frameworks that the company operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements. The key laws and regulations we considered in this context included the Companies Act 2006, and local tax legislation.
In addition, we considered provisions of other laws and regulations that do not have a direct effect on the financial statements but compliance with which may be fundamental to the company’s ability to operate or to avoid a material penalty.
XEROX IBS NI LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBER OF XEROX IBS NI LIMITED
- 9 -
Audit response to risks identified
Our procedures to respond to the risks identified included the following:
Reviewing the financial statement disclosures and testing to supporting documentation to assess compliance with provisions of relevant laws and regulations described as having a direct effect on the financial statements;
Enquiring of management concerning actual and potential litigation and claims;
Performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud;
Reading minutes of meetings of those charged with governance and reviewing correspondence with tax authorities; and
In addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments; assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.
We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.
Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. In addition, as with any audit, there remains a higher risk of non-detection of irregularities, as they may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal controls. We are not responsible for preventing non-compliance and cannot be expected to detect non-compliance with all laws and regulations.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
XEROX IBS NI LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBER OF XEROX IBS NI LIMITED
- 10 -
This report is made solely to the company's member in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's member those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's member for our audit work, for this report, or for the opinions we have formed.
Mr Nigel Moore FCA
Senior Statutory Auditor
For and on behalf of GMcG BELFAST
28 March 2024
Chartered Accountants
Statutory Auditor
Alfred House
19 Alfred Street
Belfast
BT2 8EQ
XEROX IBS NI LIMITED
STATEMENT OF PROFIT AND LOSS AND OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2022
- 11 -
2022
2021
Notes
£
£
Revenue
4
2,810,217
3,155,874
Cost of sales
(1,512,478)
(1,780,871)
Gross profit
1,297,739
1,375,003
Administrative expenses
(1,841,107)
(1,609,782)
Other operating income
9,533
Exceptional administrative expenses
5
(331,168)
(314,526)
Operating loss
7
(874,536)
(539,772)
Finance income
10
25
Finance costs
11
(23,235)
(663)
Loss before taxation
(897,771)
(540,410)
Tax on loss
12
(9,211)
12,488
Loss for the financial year
(906,982)
(527,922)
Other comprehensive income
-
-
Total comprehensive income for the year
(906,982)
(527,922)
The statement of profit and loss and other comprehensive income has been prepared on the basis that all operations are continuing operations.
XEROX IBS NI LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2022
31 December 2022
- 12 -
2022
2021
Notes
£
£
Non-current assets
Property, plant and equipment
13
284,541
200,701
Current assets
Inventories
15
83,193
92,952
Trade and other receivables
16
631,152
994,340
Cash and cash equivalents
392,676
351,349
1,107,021
1,438,641
Current liabilities
17
1,551,907
628,560
Net current (liabilities)/assets
(444,886)
810,081
Total assets less current liabilities
(160,345)
1,010,782
Non-current liabilities
18
(57,806)
(7,425)
Provisions for liabilities
19
(314,526)
Net (liabilities)/assets
(218,151)
688,831
Equity
Called up share capital
22
90,444
90,444
Share premium
89,001
89,001
Retained earnings
(397,596)
509,386
Total equity
(218,151)
688,831
The financial statements were approved by the board of directors and authorised for issue on 28 March 2024 and are signed on its behalf by:
Ms C A Shephard
Director
Company Registration No. NI028666
XEROX IBS NI LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2022
- 13 -
Share capital
Share premium
Retained earnings
Total
£
£
£
£
Balance at 1 January 2021
90,444
89,001
1,037,308
1,216,753
Loss and total comprehensive income for the year
-
-
(527,922)
(527,922)
Balance at 31 December 2021
90,444
89,001
509,386
688,831
Loss and total comprehensive income for the year
-
-
(906,982)
(906,982)
Balance at 31 December 2022
90,444
89,001
(397,596)
(218,151)
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
- 14 -
1
Summary of significant accounting policies
Company information
Xerox IBS NI Limited is a private company limited by shares incorporated in Northern Ireland. The registered office is Forsyth House, Cromac Square, Belfast, BT2 8LA. The principal place of business is Plaza 211, Blanchardstown Corporate Park 2, Blanchardstown, Dublin 15, D15 AP2D.
1.1
Basis of preparation
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 101 'Reduced Disclosure Framework' and the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
The company has taken advantage of the following disclosure exemptions under FRS 101:
the requirements of paragraphs 45(b) and 46-52 of IFRS 2 Share based payment
th requirements of paragraphs 62, B64(d), B64(e), B64(g), B64(h), B64(j) to B64(m), B64(n)(ii), B64(o)(ii), B64(p), B64(q)(ii), B66 and B67 of IFRS 3 Business Combinations
the requirements of paragraph 33(c) of IFRS 5 Non Current Assets Held For Sale and Discontinued Operations
the requirements of IFRS 7 Financial Instruments: Disclosures
the requirements of paragraphs 91-99 of IFRS 13 Fair Value Measurement
the requirement in paragraph 38 of IAS 1 'Presentation of Financial Statements' to present comparative information in respect of:
• paragraph 79(a)(iv) of IAS 1;
• paragraph 73(e) of IAS 16 Property, Plant and Equipment;
• paragraph 118(e) of IAS 38 Intangible Assets;
• paragraphs 76 and 79(d) of IAS 40 Investment Property; and
• paragraph 50 of IAS 41 Agriculture
the requirements of paragraphs 10(d), 10(f), 16, 38A, 38B, 38C, 38D, 40A, 40B, 40C, 40D, 111 and 134-136 of IAS 1 Presentation of Financial Statements
the requirements of IAS 7 Statement of Cash Flows
the requirements of paragraphs 30 and 31 of IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors
the requirements of paragraph 17 and 18A of IAS 24 Related Party Disclosures
the requirements in IAS 24 Related Party Disclosures to disclose related party transactionentered into between two or more members of a group, provided that any subsidiary which is a party to the transaction is wholly owned by such a member
the requirements of paragraphs 134(d)-134(f) and 135(c)-135(e) of IAS 36 Impairment of Assets.
1.2
Going concern
The financial statements have been prepared on a goingtrue concern basis, which assumes that the company has adequate financial resources to continue in operational existence for at least 12 months from the date of approval of these financial statements.
The directors, having regard to the continued support of its ultimate parent Xerox Holdings Corporation, have a reasonable expectation that the company will have adequate financial resources to continue in operational existence for at least 12 months from the date of approval of these financial statements and consider that it is appropriate to adopt the going concern basis in preparing the financial statements.
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Summary of significant accounting policies (Continued)
- 15 -
1.3
Revenue recognition
Revenue is measured at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes.
The company recognises revenue when performance obligations have been satisfied and for the company this is when the services have transferred to the customer and the customer has control of these. The company bases its estimate of return on historical results, taking into consideration the type of customer, the type of transaction and the specifics of each arrangement.
The company’s client contractual term are normally 1–5 years, the contractual period are shorter and correspond to the period covered in the specific volume request from the respective client, which is stipulated in each contract and is normally a shorter period, e.g. between 1–6 months. These are identified as the company’s performance obligations.
Revenues associated with service arrangements - maintenance and document management - are generally recognised as maintenance and printing services are rendered, which is generally on the basis of the number of images produced. Accordingly, this recognition methodology requires the company to estimate customer usage at the end of a period since the customer is typically not invoiced for that usage until the following period. Normally this estimation process is straightforward and objective based on significant history with different types of customers and device usage as well as the fact that a majority of devices have connectivity to Xerox so usage data can be read and collected remotely.
Equipment
Equipment sales that require the company to install the product at the customer location. Revenue is recognised when the equipment is delivered to and installed at the customer location and customer acceptance has been received.
Service
Revenues associated with service arrangements - maintenance and document management - are recognised as maintenance and printing services are rendered, which is generally on the basis of the number of images produced. Accordingly, this recognition methodology requires an estimate of customer usage at the end of a period since the customer is typically not invoiced for that usage until the following period. Normally this estimation process is straightforward and objective based on significant history with different types of customers and device usage as well as the fact that a majority of our devices have connectivity to Xerox so usage data can be read and collected remotely.
Supplies
Supplies revenue generally is recognised upon shipment or utilisation by customer in accordance with sales terms.
1.4
Property, plant and equipment
Property, plant and equipment are initially measured at historical cost less accumulated deprecation and impairment losses.
Depreciation is calculated using the straight-line method to allocate their cost to their residual values over their estimated useful lives, as follows:
Plant and equipment
3 - 5 years
Capitalised software
3 - 5 years
Motor vehicles
5 years
Right-of-use assets
Over term of relevant lease
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit or loss.
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Summary of significant accounting policies (Continued)
- 16 -
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
1.5
Inventories
Inventories are stated at the lower of cost and net realisable value. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition.
Inventories held for distribution at no or nominal consideration are measured at the lower of replacement cost and cost, adjusted where applicable for any loss of service potential.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of inventories over its net realisable value is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
1.6
Cash and cash equivalents
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.7
Financial instruments
Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Financial assets
The Company classifies its financial assets in the following categories:
• Amortised cost.
• Fair value through profit or loss (FVTPL)
• Fair value through other comprehensive income (FVOCI)
The classification depends on the purpose for which the financial assets were acquired i.e. the entity’s business model for managing the financial assets and/or the contractual cash flow characteristics of the financial asset.
Regular way purchases and sales of financial assets are recognised on trade date being the date on which the group commits to purchase or sell the asset. Financial assets are derecognised when the rights to receive cash flows from the financial assets have expired or have been transferred and the company has transferred substantially all the risks and rewards of ownership.
At initial recognition, the company measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through profit or loss (FVPL), transaction costs that are directly attributable to the acquisition of the financial asset. Transaction costs of financial assets carried at FVPL are expensed in profit or loss.
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Summary of significant accounting policies (Continued)
- 17 -
Financial assets at amortised cost
The company classifies its financial assets as at amortised cost only if both of the following criteria are met (and are not designated as FVTPL):
The asset is held within a business model whose objective is to collect the contractual cash flows, and
The contractual terms of the financial asset give rise to cash flows that are solely payments of principal and interest.
Subsequent to initial recognition these are measured at amortised cost using the effective interest method. Interest income from these financial assets is included in finance income using the effective interest rate method. Any gain or loss arising on derecognition is recognised directly in profit or loss and presented in other (expenses)/income together with foreign exchange gains and losses. Impairment losses are presented as separate line item in the profit or loss under ‘net impairment losses on financial and contract assets.
Impairment of financial assets
The Company assesses on a forward-looking basis the expected credit loss associated with its financial assets. The impairment methodology applied depends on whether there has been a significant increase in credit risk.
For trade receivables, the company applies the simplified approach permitted by IFRS 9, which requires expected lifetime losses to be recognised from initial recognition of the receivables.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including trade and other payables, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Summary of significant accounting policies (Continued)
- 18 -
Other financial liabilities
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.
Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
1.8
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.9
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Summary of significant accounting policies (Continued)
- 19 -
1.10
Provisions
Provisions are recognised when the company has a legal or constructive present obligation as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.
The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the reporting end date, taking into account the risks and uncertainties surrounding the obligation. Where the effect of the time value of money is material, the amount expected to be required to settle the obligation is recognised at present value. When a provision is measured at present value, the unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
1.11
Employee benefits
The costs of short-term employee benefits are recognised as a payment obligation and expense when they are due.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.12
Retirement benefits
The company pays contributions to publicly or privately administered pension insurance plans on a mandatory, contractual or voluntary basis. The company has no further payment obligations once the contributions have been paid. The contributions are recognised as employee benefit expense when they are due.
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Summary of significant accounting policies (Continued)
- 20 -
1.13
Leases
The company determines at inception whether an arrangement is a lease. Leases do not include assets of a specialised nature, or the transfer of ownership at the end of the lease, and the exercise of end-of-lease purchase options, which are primarily in equipment leases, is not reasonably assured at lease inception. Accordingly, the two primary criteria used to classify transactions as operating or finance leases are:
i.a review of the lease term to determine if it is equal to or greater than 75% of the economic life of the asset, and
ii.a review of the present value of the minimum lease payments to determine if they are equal to or greater than 90% of the fair market value of the asset at the inception of the lease.
Right-of-use ("ROU") assets represent the company's right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. The company also assess arrangements for goods or services to determine if the arrangement contains a lease at its inception. This assessment first considers whether there is an implicitly or explicitly identified asset in the arrangement and then whether there is a right to control the use of the asset. If there is an embedded lease within a contract, the company determines the classification of the lease at the lease inception date consistent with standalone leases of assets.
Operating leases are included in Other long-term assets, Accrued expenses and Other current liabilities, and Other long-term liabilities in the Statement of Financial Position.
Finance leases are included in Land, buildings and equipment, net, Accrued expenses and Other current liabilities, and Other long-term liabilities in the Statement of Financial Position.
Operating lease ROU assets and liabilities are recognised at the commencement date based on the present value of lease payments over the lease term. Since the implicit rate for most of the leases is not readily determinable, the incremental borrowing rate is used based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that the company would have to pay to borrow, on a collateralised basis, an amount equal to the lease payments, in a similar economic environment and over a similar term. The rate is dependent on several factors, including the lease term and currency of the lease payments.
Lease terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease, as there is not reasonable certainty at lease inception that these options will be exercised. The company generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve months or less. Leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives.
Lease expense is recognised on a straight-line basis over the lease term. The company has lease agreements with lease and non-lease components. These components are accounted for separately for vehicle and equipment leases. The company accounts for the lease and non-lease components as a single lease component for real estate leases of offices and warehouses.
The impairment of ROU assets is reviewed consistent with the approach applied for other long-lived assets. The recoverability of our long-lived assets is reviewed when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on the ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The company has elected to include the carrying amount of operating lease liabilities in any tested asset group and include the associated operating lease payments in the undiscounted future pre-tax cash flows.
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Summary of significant accounting policies (Continued)
- 21 -
The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, which is generally the case for leases in the company, the lessee’s incremental borrowing rate is used, being the rate that the individual lessee would have to pay to borrow the funds necessary to obtain an asset of similar value to the right-of-use asset in a similar economic environment with similar terms, security and conditions.
To determine the incremental borrowing rate, the company:
Where possible, uses recent third-party financing received by the individual lessee as a starting point, adjusted to reflect changes in financing conditions since third party financing was received;
Uses a build-up approach that starts with a risk-free interest rate adjusted for credit risk for leases held by the company, which does not have recent third party financing; and
Makes adjustments specific to the lease, e.g. term, currency and security.
The company used incremental borrowing rates specific to each lease and the rate of 2.37% (average rate: 2.37%).
1.14
Foreign currency translation
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
Items included in the financial statements of the company are measured using the currency of the primary economic environment in which the company operates ("the functional currency"). The financial statements are present in sterling, which is also the company's functional currency.
1.15
Exceptional items are transactions that fall within the ordinary activities of the company but are presented separately due to their size or incidence.
1.16
Government grants related to income are recognised as a reduction of related expenses in the statement of comprehensive income when there is a reasonable assurance that the entity will comply with the conditions attached to the grant and that the grants will be received. The timing and pattern of recognition of government grants is made on a systematic basis over the periods in which the company recognises the related expenses or losses that the grants are intended to compensate.
2
General information
The principal activity of Xerox IBS NI Limited is to sell and provide maintenance of office equipment.
Xerox IBS NI Limited is a private company limited by shares incorporated in Northern Ireland. The registered office is Forsyth House, Cromac Square, Belfast, BT2 8LA and the principal place of business is Plaza 211, Blanchardstown Corporate Park 2, Blanchardstown, Dublin 15, D15 AP2D.
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 22 -
3
Critical judgements and estimates in applying the Company's acounting policies
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.
Useful economic lives of property, plant & equipment
The annual depreciation charge on property, plant and equipment depends primarily on the estimated lives of each type of asset and estimates of residual values. The directors regularly review these asset lives and change them as necessary to reflect current thinking on remaining lives in light of prospective economic utilisation and physical condition of the assets concerned. Changes in asset lives can have a significant impact on depreciation and amortisation charges for the period. Detail of the useful lives is included in the accounting policies.
Inventories
At each balance sheet date the company's inventories are assessed for impairment. If stock is impaired, the carrying amount is reduced to its anticipated selling price less costs to complete and sell. The assessment of the selling price of such stock involves an element of estimation uncertainty.
Trade receivables
The company makes an estimate of the recoverable value of trade debtors. When assessing impairment management considers factors including the ageing profile of debtors and historical experience.
Taxation
Judgements are made in relation to the calculation of certain aspects of the year end tax provisions and the respective tax charge. The management used external professional advice to support the year end provisions.
4
Revenue
Represents amounts receivable for goods and services net of VAT and trade discounts and is generated from activities primarily in Northern Ireland.
2022
2021
£
£
Revenue analysed by class of business
Equipment revenue
206,833
808,957
Service, maintenance and rentals
2,598,676
2,337,280
Supplies
4,708
9,637
2,810,217
3,155,874
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
4
Revenue (Continued)
- 23 -
2022
2021
£
£
Other significant revenue
Interest income
-
25
Other operating income
-
9,533
5
Exceptional administrative expense
2022
2021
£
£
Restructuring costs
331,168
314,526
The company restructured certain elements of its internal processes during the current and prior year. The exceptional expenses recognised in the year ended 31 December 2022 relate to redundancy and other associated costs arising from these changes.
6
Auditor's remuneration
2022
2021
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the company
7,700
7,000
For other services
Taxation compliance services
5,000
4,500
All other non-audit services
16,550
11,990
21,550
16,490
7
Operating loss
2022
2021
Operating loss for the year is stated after charging/(crediting):
£
£
Exchange losses/(gains)
5,520
(11,202)
Depreciation of owned property, plant and equipment
93,634
98,276
Operating lease charges
27,013
40,677
Defined contribution pension costs
66,786
78,558
Exchange differences recognised in profit or loss during the year, except for those arising on financial instruments measured at fair value through profit or loss, amounted to a loss of £5,520 (2021 - gain of £11,202).
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 24 -
8
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2022
2021
Number
Number
Number of management staff
5
6
Number of sales staff
4
4
Number of service staff
24
24
Total
33
34
Their aggregate remuneration comprised:
2022
2021
£
£
Wages and salaries
1,200,910
1,063,156
Social security costs
166,115
131,379
Pension costs
66,786
78,558
1,433,811
1,273,093
The aggregate remuneration is stated after netting off grants received in relation to coronavirus job retention scheme totalling £Nil (2021 - £89,653).
9
Directors' remuneration
2022
2021
£
£
Remuneration for qualifying services
25,347
62,335
Company pension contributions to defined contribution schemes
3,001
5,467
28,348
67,802
The directors are the key management personnel of the company. Not all directors are paid by the company. Some directors are paid by another Xerox entity.
10
Finance income
2022
2021
£
£
Interest income
Interest receivable from group companies
25
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 25 -
11
Finance costs
2022
2021
£
£
Interest payable to group undertakings
20,490
Leased assets interest charge
2,745
663
23,235
663
12
Taxation
2022
2021
£
£
Deferred tax
Origination and reversal of timing differences
9,211
(12,488)
The actual charge/(credit) for the year can be reconciled to the expected credit for the year based on the profit or loss and the standard rate of tax as follows:
2022
2021
£
£
Loss before taxation
(897,771)
(540,410)
Expected tax credit based on the standard rate of corporation tax in the UK of 19.00% (2021: 19.00%)
(170,576)
(102,678)
Expenses not deductible for tax purposes, other than goodwill amortisation and impairment
202
Adjustment in respect of rate change
2,210
(20,626)
Group relief
177,577
110,614
Taxation charge/(credit) for the year
9,211
(12,488)
An increase in the UK corporation tax rate from 19% to 25% (effective from 1 April 2023) was enacted in Finance Act 2021, and the deferred tax asset as at 31 December 2022 has been calculated based on this rate.
This will have a consequential effect on the company's future tax charge.
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 26 -
13
Property, plant and equipment
Plant and equipment
Capitalised software
Motor vehicles
Right-of-use assets
Total
£
£
£
£
£
Cost
At 1 January 2022
546,088
25,132
2,646
28,670
602,536
Recognition of right-of-use asset on implementation of IFRS 16
Additions
89,473
88,001
177,474
Disposals
(183,379)
(183,379)
At 31 December 2022
452,182
25,132
2,646
116,671
596,631
Depreciation and impairment
At 1 January 2022
360,062
25,132
2,646
13,995
401,835
Depreciation charged in the year
76,668
16,966
93,634
Eliminated in respect of disposals
(183,379)
(183,379)
At 31 December 2022
253,351
25,132
2,646
30,961
312,090
Carrying amount
At 31 December 2022
198,831
85,710
284,541
At 31 December 2021
186,026
14,675
200,701
The depreciation for the period has been charged as follows:
Cost of sales
76,668
Administration expenses
16,966
93,634
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 27 -
14
Leases
This note provides information for leases where the company is a lessee.
(i) Amounts recognised in the statement of financial position
The balance sheet shows the following amounts relating to leases:
31 Dec 2022
31 Dec 2021
Right-of-use assets
£
£
Buildings
-
-
Vehicles
85,710
14,675
85,710
14,675
Lease liability
Current
28,000
7,250
Non-current
57,710
7,425
85,710
14,675
Additions to the right-of-use assets during the 2022 financial year were £88,001 (2021 - £Nil).
(ii) Amounts recognised in the statement of profit or loss.
The statement of profit or loss shows the following amounts relating to leases:
2022
2021
£
£
Depreciation of right-of-use assets
Vehicle
16,966
15,095
16,966
15,095
Interest expense (included in finance cost)
2,745
663
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
14
Leases (Continued)
- 28 -
Future minimum lease payments as at 31 December 2022 are as follows:
2022
2021
£
£
No Later than 1 year
28,000
7,250
Later than one year and not later than five years
57,710
7,425
Later than 5 year
-
-
85,710
14,675
The total cash outflow for leases in 2022 was £20,052 (2021 - £15,754).
15
Inventories
2022
2021
£
£
Finished goods and goods for resale
83,193
92,952
The directors believe that the replacement of inventories in not materially different from the book value.
16
Trade and other receivables
2022
2021
Amounts falling due within one year:
£
£
Trade receivables
282,349
574,789
Receivables from related parties
142,139
233,855
Prepayments and accrued income
129,935
99,756
554,423
908,400
2022
2021
Amounts falling due after more than one year:
£
£
Deferred tax asset (note 20)
76,729
85,940
631,152
994,340
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 29 -
17
Current liabilities
2022
2021
Notes
£
£
Lease liabilities
14
27,904
7,250
Trade payables
48,563
70,615
Amounts due to related parties
1,055,186
76,216
Taxation and social security
123,890
228,227
Other payables
37,657
19,824
Accruals and deferred income
258,707
226,428
1,551,907
628,560
Amounts due to group undertakings are unsecured, interest free, have no fixed date of repayment and are repayable on demand.
18
Non-current liabilities
2022
2021
Notes
£
£
Lease liabilities
14
57,806
7,425
19
Provisions for liabilities
2022
2021
£
£
Restructuring reserve
-
314,526
20
Deferred tax asset
The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:
2022
2021
Balances:
£
£
Fixed asset timing differences
74,674
82,810
Other timing differences
2,055
3,130
76,729
85,940
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
20
Deferred tax asset (Continued)
- 30 -
2022
Movements in the year:
£
Asset at 1 January 2022
(85,940)
Charge to profit or loss
9,211
Asset at 31 December 2022
(76,729)
At the balance sheet date there exists a deferred tax asset of £76,729 (2021 - £85,940) at a corporation tax rate of 25% (2021 - 25%). The deferred tax asset arises in respect of depreciation in excess of capital allowances and other timing differences.
Deferred tax assets are recognised for tax loss carry forwards to the extent that the realisation of the related tax benefit through future taxable profits and reversal of timing differences is probable. The company did not recognise deferred tax assets of £13,509 in respect of capital losses amounting to £54,037 that can be carried forward against future taxable capital income.
21
Post-employment benefits
2022
2021
Defined contribution schemes
£
£
Current year contributions
66,786
78,558
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
XEROX IBS NI LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 31 -
22
Share capital and premium
2022
2021
£
£
Ordinary share capital
Issued and fully paid
90,444 Ordinary share capital of £1 each
90,444
90,444
23
Related party transactions
Remuneration of key management personnel
The directors are the key management personnel of the company. Remuneration paid to the directors during the year is disclosed in note 9.
Other information
As the company is a wholly owned subsidiary, advantage has been taken of the exemption from disclosing related party transactions with other wholly owned group companies.
24
Ultimate controlling party
The ultimate parent undertaking, controlling party and the largest group in which the results of Xerox IBS NI Limited are consolidated is that of Xerox Holdings Corporation, which is incorporated in the United States of America. Copies of the Xerox Holdings Corporation Annual Report and financial statements may be obtained from the Investor Relations Department, Xerox Corporation, 210 Merritt 7, Norwalk CT 06851-1056, USA; www.xerox.com.
The smallest group in which the results of Xerox IBS NI Limited are consolidated is that of Xerox Investments Europe B.V., which is registered in The Netherlands. Copies of the Xerox Investments Europe B.V. Annual Report and financial statements may be obtained from Xerox Investments Europe B.V., Rijnzathe 12, 3454 PV De Meern, The Netherlands.
The immediate parent of the company is Xerox Capital (Europe) Limited which is registered in the United Kingdom, Registration Number 03070508. The registered office for the parent company is Building 4, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH.
2022-12-312022-01-01falseCCH SoftwareCCH Accounts Production 2023.200Mr B BaranMr Anthony McPhillipsMs A C BeckmanMs C A ShephardMs E MaherMr R ClarkeMr D S CassidyMr S FarrellMs A Albertoni906982NI0286662022-01-012022-12-31NI028666bus:Director42022-01-012022-12-31NI028666bus:Director52022-01-012022-12-31NI028666bus:Director62022-01-012022-12-31NI028666bus:Director72022-01-012022-12-31NI028666bus:Director82022-01-012022-12-31NI028666bus:CompanySecretary12022-01-012022-12-31NI028666bus:Director12022-01-012022-12-31NI028666bus:Director22022-01-012022-12-31NI028666bus:Director32022-01-012022-12-31NI028666bus:RegisteredOffice2022-01-012022-12-31NI028666bus:Agent12022-01-012022-12-31NI0286662022-12-31NI0286662021-01-012021-12-31NI028666core:Exceptional12022-01-012022-12-31NI028666core:Exceptional12021-01-012021-12-31NI028666core:RetainedEarningsAccumulatedLosses2021-01-012021-12-31NI028666core:RetainedEarningsAccumulatedLosses2022-01-012022-12-31NI0286662021-12-31NI028666core:PlantMachinery2022-12-31NI028666core:FurnitureFittings2022-12-31NI028666core:MotorVehicles2022-12-31NI028666core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2022-12-31NI028666core:PlantMachinery2021-12-31NI028666core:FurnitureFittings2021-12-31NI028666core:MotorVehicles2021-12-31NI028666core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2021-12-31NI028666core:CurrentFinancialInstrumentscore:WithinOneYear2022-12-31NI028666core:CurrentFinancialInstrumentscore:WithinOneYear2021-12-31NI028666core:Non-currentFinancialInstrumentscore:AfterOneYear2022-12-31NI028666core:Non-currentFinancialInstrumentscore:AfterOneYear2021-12-31NI028666core:CurrentFinancialInstruments2022-12-31NI028666core:CurrentFinancialInstruments2021-12-31NI028666core:ShareCapital2022-12-31NI028666core:ShareCapital2021-12-31NI028666core:SharePremium2022-12-31NI028666core:SharePremium2021-12-31NI028666core:RetainedEarningsAccumulatedLosses2022-12-31NI028666core:RetainedEarningsAccumulatedLosses2021-12-31NI028666core:ShareCapital2020-12-31NI028666core:SharePremium2020-12-31NI028666core:RetainedEarningsAccumulatedLosses2020-12-31NI0286662020-12-31NI028666core:PlantMachinery2022-01-012022-12-31NI028666core:FurnitureFittings2022-01-012022-12-31NI028666core:MotorVehicles2022-01-012022-12-31NI028666core:UKTax2022-01-012022-12-31NI028666core:UKTax2021-01-012021-12-31NI028666core:PlantMachinery2021-12-31NI028666core:FurnitureFittings2021-12-31NI028666core:MotorVehicles2021-12-31NI028666core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2021-12-31NI0286662021-12-31NI028666core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2022-01-012022-12-31NI028666core:Non-currentFinancialInstruments2022-12-31NI028666core:Non-currentFinancialInstruments2021-12-31NI028666bus:PrivateLimitedCompanyLtd2022-01-012022-12-31NI028666bus:FRS1022022-01-012022-12-31NI028666bus:Audited2022-01-012022-12-31NI028666bus:FullAccounts2022-01-012022-12-31xbrli:purexbrli:sharesiso4217:GBP